Literature DB >> 19850007

Loss of ovarian function in mice results in abrogated skeletal muscle PPARdelta and FoxO1-mediated gene expression.

Nicole H Rogers1, James W Perfield, Katherine J Strissel, Martin S Obin, Andrew S Greenberg.   

Abstract

Menopause, the age-related loss of ovarian hormone production, promotes increased adiposity and associated metabolic pathology, but molecular mechanisms remain unclear. We previously reported that estrogen increases skeletal muscle PPARdelta expression in vivo, and transgenic mice overexpressing muscle-specific PPARdelta are reportedly protected from diet-induced obesity. We thus hypothesized that obesity observed in ovariectomized mice, a model of menopause, may result in part from abrogated expression of muscle PPARdelta and/or downstream mediators such as FoxO1. To test this hypothesis, we ovariectomized (OVX) or sham-ovariectomized (SHM) 10-week old female C57Bl/6J mice, and subsequently harvested quadriceps muscles 12weeks later for gene expression studies. Compared to SHM, muscle from OVX mice displayed significantly decreased expression of PPARdelta (3.4-fold), FoxO1 (4.5-fold), PDK-4 (2.3-fold), and UCP-2 (1.8-fold). Consistent with studies indicating PPARdelta and FoxO1 regulate muscle fiber type, we observed dramatic OVX-specific decreases in slow isoforms of the contractile proteins myosin light chain (11.1-fold) and troponin C (11.8-fold). In addition, muscles from OVX mice expressed 57% less myogenin (drives type I fiber formation), 2-fold more MyoD (drives type II fiber formation), and 1.6-fold less musclin (produced exclusively by type II fibers) than SHM, collectively suggesting a shift towards less type I oxidative fibers. Finally, and consistent with changes in PPARdelta and FoxO1 activity, we observed decreased expression of atrogin-1 (2.3-fold) and MuRF-1 (1.9-fold) in OVX mice. In conclusion, muscles from ovariectomized mice display decreased PPARdelta and FoxO1 expression, abrogated expression of downstream targets involved in lipid and protein metabolism, and gene expression profiles indicating less type I oxidative fibers. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850007      PMCID: PMC2829241          DOI: 10.1016/j.bbrc.2009.10.072

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways.

Authors:  Tara M D'Eon; Sandra C Souza; Mark Aronovitz; Martin S Obin; Susan K Fried; Andrew S Greenberg
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

2.  Ovarian suppression with gonadotropin-releasing hormone agonist reduces whole body protein turnover in women.

Authors:  Michael J Toth; Cynthia K Sites; Dwight E Matthews; Peter R Casson
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-04-18       Impact factor: 4.310

3.  Musclin gene expression is strongly related to fast-glycolytic phenotype.

Authors:  S Banzet; N Koulmann; H Sanchez; B Serrurier; A Peinnequin; A X Bigard
Journal:  Biochem Biophys Res Commun       Date:  2006-12-20       Impact factor: 3.575

4.  PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes.

Authors:  Michael Schuler; Faisal Ali; Céline Chambon; Delphine Duteil; Jean-Marc Bornert; Aubry Tardivel; Béatrice Desvergne; Walter Wahli; Pierre Chambon; Daniel Metzger
Journal:  Cell Metab       Date:  2006-11       Impact factor: 27.287

5.  Myogenin induces higher oxidative capacity in pre-existing mouse muscle fibres after somatic DNA transfer.

Authors:  Merete Ekmark; Eirik Grønevik; Peter Schjerling; Kristian Gundersen
Journal:  J Physiol       Date:  2003-02-21       Impact factor: 5.182

6.  Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity.

Authors:  Nicole H Rogers; James W Perfield; Katherine J Strissel; Martin S Obin; Andrew S Greenberg
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

7.  Oestrogen receptor beta is expressed in adult human skeletal muscle both at the mRNA and protein level.

Authors:  A Wiik; B Glenmark; M Ekman; M Esbjörnsson-Liljedahl; O Johansson; K Bodin; E Enmark; E Jansson
Journal:  Acta Physiol Scand       Date:  2003-12

Review 8.  The emergence of the metabolic syndrome with menopause.

Authors:  Molly C Carr
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

9.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

Authors:  Trevor N Stitt; Doreen Drujan; Brian A Clarke; Frank Panaro; Yekatarina Timofeyva; William O Kline; Michael Gonzalez; George D Yancopoulos; David J Glass
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

10.  Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones.

Authors:  S M Hughes; J M Taylor; S J Tapscott; C M Gurley; W J Carter; C A Peterson
Journal:  Development       Date:  1993-08       Impact factor: 6.868

View more
  8 in total

Review 1.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

2.  Aging of the musculoskeletal system: How the loss of estrogen impacts muscle strength.

Authors:  Brittany C Collins; Eija K Laakkonen; Dawn A Lowe
Journal:  Bone       Date:  2019-03-28       Impact factor: 4.398

3.  Diminished satellite cells and elevated adipogenic gene expression in muscle as caused by ovariectomy are averted by low-magnitude mechanical signals.

Authors:  Danielle M Frechette; Divya Krishnamoorthy; Benjamin J Adler; M Ete Chan; Clinton T Rubin
Journal:  J Appl Physiol (1985)       Date:  2015-04-30

4.  Increased body fat mass and tissue lipotoxicity associated with ovariectomy or high-fat diet differentially affects bone and skeletal muscle metabolism in rats.

Authors:  Camille Tagliaferri; Jérôme Salles; Jean-François Landrier; Christophe Giraudet; Véronique Patrac; Patrice Lebecque; Marie-Jeanne Davicco; Audrey Chanet; Corinne Pouyet; Amélie Dhaussy; Alain Huertas; Yves Boirie; Yohann Wittrant; Véronique Coxam; Stéphane Walrand
Journal:  Eur J Nutr       Date:  2014-11-05       Impact factor: 5.614

5.  Estradiol modulates myosin regulatory light chain phosphorylation and contractility in skeletal muscle of female mice.

Authors:  Shaojuan Lai; Brittany C Collins; Brett A Colson; Georgios Kararigas; Dawn A Lowe
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-03-08       Impact factor: 4.310

6.  Estrogen regulates estrogen receptors and antioxidant gene expression in mouse skeletal muscle.

Authors:  Kristen A Baltgalvis; Sarah M Greising; Gordon L Warren; Dawn A Lowe
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

Review 7.  Effects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and disease.

Authors:  James A Carson; Stavros C Manolagas
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

8.  The PPARδ Agonist GW501516 Improves Lipolytic/Lipogenic Balance through CPT1 and PEPCK during the Development of Pre-Implantation Bovine Embryos.

Authors:  Muhammad Idrees; Lianguang Xu; Marwa El Sheikh; Tabinda Sidrat; Seok-Hwan Song; Myeong-Don Joo; Kyeong-Lim Lee; Il-Keun Kong
Journal:  Int J Mol Sci       Date:  2019-12-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.